AR022044A1 - DERIVATIVES OF 1,5-BENZODIAZEPINA - Google Patents
DERIVATIVES OF 1,5-BENZODIAZEPINAInfo
- Publication number
- AR022044A1 AR022044A1 ARP000102119A ARP000102119A AR022044A1 AR 022044 A1 AR022044 A1 AR 022044A1 AR P000102119 A ARP000102119 A AR P000102119A AR P000102119 A ARP000102119 A AR P000102119A AR 022044 A1 AR022044 A1 AR 022044A1
- Authority
- AR
- Argentina
- Prior art keywords
- benzodiazepina
- derivatives
- cck
- obesity
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe un proceso para la preparacion de un compuesto enantioméricamente enriquecido, de formula (1), composiciones farmacéuticas que lo contienen yel uso de las mismas, para el tratamiento de enfermedades o condiciones mediadas por el CCK-A,ta les como la obesidad.A process is described for the preparation of an enantiomerically enriched compound, of formula (1), pharmaceutical compositions containing it and the use thereof, for the treatment of diseases or conditions mediated by CCK-A, such as obesity.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9910366.5A GB9910366D0 (en) | 1999-05-06 | 1999-05-06 | 1,5-Benzodiazepine Derivatives |
| GBGB0008179.4A GB0008179D0 (en) | 2000-04-05 | 2000-04-05 | Chemical process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022044A1 true AR022044A1 (en) | 2002-09-04 |
Family
ID=26244033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102119A AR022044A1 (en) | 1999-05-06 | 2000-05-03 | DERIVATIVES OF 1,5-BENZODIAZEPINA |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1212305A2 (en) |
| JP (1) | JP2002544200A (en) |
| KR (1) | KR20020012567A (en) |
| CN (1) | CN1161345C (en) |
| AR (1) | AR022044A1 (en) |
| AU (1) | AU4754800A (en) |
| BR (1) | BR0010338A (en) |
| CA (1) | CA2370801A1 (en) |
| CO (1) | CO5170461A1 (en) |
| CZ (1) | CZ20013988A3 (en) |
| HK (1) | HK1046138A1 (en) |
| HU (1) | HUP0201181A3 (en) |
| IL (1) | IL146124A0 (en) |
| MX (1) | MXPA01011267A (en) |
| MY (1) | MY138319A (en) |
| NO (1) | NO20015397L (en) |
| NZ (1) | NZ515048A (en) |
| PE (1) | PE20010110A1 (en) |
| PL (1) | PL351546A1 (en) |
| TR (1) | TR200103169T2 (en) |
| WO (1) | WO2000068209A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005035793A2 (en) * | 2003-10-09 | 2005-04-21 | Decode Genetics Ehf. | Cckar markers and haplotypes associated with extreme weight conditions |
| JP4069159B2 (en) | 2004-05-25 | 2008-04-02 | ファイザー・プロダクツ・インク | Tetraazabenzo [e] azulene derivatives and analogs thereof |
| KR20220150270A (en) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | GPR119 agonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9307833D0 (en) * | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
-
2000
- 2000-05-03 AR ARP000102119A patent/AR022044A1/en unknown
- 2000-05-04 WO PCT/EP2000/003982 patent/WO2000068209A2/en not_active Application Discontinuation
- 2000-05-04 HU HU0201181A patent/HUP0201181A3/en unknown
- 2000-05-04 EP EP00929488A patent/EP1212305A2/en not_active Withdrawn
- 2000-05-04 PL PL00351546A patent/PL351546A1/en not_active Application Discontinuation
- 2000-05-04 AU AU47548/00A patent/AU4754800A/en not_active Abandoned
- 2000-05-04 IL IL14612400A patent/IL146124A0/en unknown
- 2000-05-04 MY MYPI20001917A patent/MY138319A/en unknown
- 2000-05-04 NZ NZ515048A patent/NZ515048A/en unknown
- 2000-05-04 CN CNB008099324A patent/CN1161345C/en not_active Expired - Fee Related
- 2000-05-04 MX MXPA01011267A patent/MXPA01011267A/en not_active Application Discontinuation
- 2000-05-04 KR KR1020017014075A patent/KR20020012567A/en not_active Application Discontinuation
- 2000-05-04 CO CO00031982A patent/CO5170461A1/en not_active Application Discontinuation
- 2000-05-04 CZ CZ20013988A patent/CZ20013988A3/en unknown
- 2000-05-04 JP JP2000617189A patent/JP2002544200A/en active Pending
- 2000-05-04 PE PE2000000415A patent/PE20010110A1/en not_active Application Discontinuation
- 2000-05-04 BR BR0010338-1A patent/BR0010338A/en not_active IP Right Cessation
- 2000-05-04 CA CA002370801A patent/CA2370801A1/en not_active Abandoned
- 2000-05-04 TR TR2001/03169T patent/TR200103169T2/en unknown
-
2001
- 2001-11-05 NO NO20015397A patent/NO20015397L/en not_active Application Discontinuation
-
2002
- 2002-10-23 HK HK02107684.4A patent/HK1046138A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ515048A (en) | 2004-01-30 |
| TR200103169T2 (en) | 2002-04-22 |
| AU4754800A (en) | 2000-11-21 |
| CN1161345C (en) | 2004-08-11 |
| IL146124A0 (en) | 2002-07-25 |
| NO20015397D0 (en) | 2001-11-05 |
| WO2000068209A2 (en) | 2000-11-16 |
| KR20020012567A (en) | 2002-02-16 |
| MY138319A (en) | 2009-05-29 |
| CN1362949A (en) | 2002-08-07 |
| EP1212305A2 (en) | 2002-06-12 |
| CO5170461A1 (en) | 2002-06-27 |
| MXPA01011267A (en) | 2002-05-06 |
| JP2002544200A (en) | 2002-12-24 |
| HUP0201181A3 (en) | 2003-10-28 |
| BR0010338A (en) | 2002-02-13 |
| CA2370801A1 (en) | 2000-11-16 |
| PL351546A1 (en) | 2003-05-05 |
| CZ20013988A3 (en) | 2002-02-13 |
| NO20015397L (en) | 2001-11-05 |
| HK1046138A1 (en) | 2002-12-27 |
| PE20010110A1 (en) | 2001-03-05 |
| WO2000068209A3 (en) | 2001-03-01 |
| HUP0201181A2 (en) | 2002-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2000001860A0 (en) | Hypolipidemic benzothiazepine compounds. | |
| IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
| SE9903544D0 (en) | Novel compounds | |
| BR0010555A (en) | Neuraminidase Inhibitors | |
| ECSP034732A (en) | DERIVATIVE OF PHENETHANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| PT1213296E (en) | DERIVATIVES OF GLUCOPIRANOSILOXIPIRAZOLE MEDICAL COMPOSITIONS THAT CONTAIN THEM AND INTERMEDIARIES IN THEIR PRODUCTION | |
| PA8547701A1 (en) | NUCLEOSIDS 4 SUBSTITUTED. | |
| BR0011448A (en) | Amide Substituted Imidazoquinolines | |
| LU91145I9 (en) | ||
| BR0312729A (en) | New indole-3-sulfur derivatives | |
| MXPA02007942A (en) | Pyrrolopyrimidinone derivatives, process of preparation and use. | |
| ATE406893T1 (en) | PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND HAVING IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) ACTION AND USE THEREOF | |
| DE60034240D1 (en) | DRUGS FOR THE TREATMENT OF MALIGNER TUMORS | |
| WO2004026863A8 (en) | Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors | |
| BR0314577A (en) | Triazole derivatives as transforming growth factor (tgf) inhibitors | |
| BR0316723A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| AR012504A1 (en) | USE OF TETRAHYDROPYRIDINE DERIVATIVES, FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES WHICH CAUSE A DEMELINATION. | |
| CL2003002565A1 (en) | COMPOUNDS DERIVED FROM 3H-QUINAZOLIN-4-ONA, ITS PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE IN THE TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MAO-B INHIBITORS, SUCH AS THE DISEASE OF ALZHEIMER AND DEMENCIER | |
| NO20020282D0 (en) | New diphenylpiperidine derivative | |
| MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| SE8505488D0 (en) | ISOSILYBIN-FREE SILIBININ | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| ES2182035T3 (en) | DERIVATIVES OF BISARILCICLOBUTENO AS CICLOOXIGENASA INHIBITORS | |
| DE69917005D1 (en) | SUBSTITUTED PYRROLOBENZIMIDAZOLE DERIVATIVES FOR ANTI-INFLAMMATION | |
| BR9909870A (en) | Pyrrolidines as inhibitors of neuraminidases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |